Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Effects of the herbal compound PC-SPES in androgen-independent prostate cancer

Feb. 28, 2001

Teikoku Hormone describes new treatments for estrogen-related diseases

Feb. 27, 2001

Telomerase-inhibitory thiazolidinones designed by Geron

Feb. 27, 2001

Isis presents new antisense oligonucleotides for cancer

Feb. 27, 2001

AN-207 selectively targets LHRH receptor-expressing ovarian cancer cells

Feb. 27, 2001

CA4P exerts antiangiogenic effects in animal lymphoma model

Feb. 27, 2001

Microbial metabolite inhibits interaction between p53 and MDM2

Feb. 27, 2001

Antitumor effects of salvicine related to its ability to induce apoptosis

Feb. 26, 2001

SR-7 disrupts G2/M transition via an apparently novel mechanism of action

Feb. 26, 2001

Enrollment complete in pivotal trial of IM-862 in AIDS-related Kaposi's sarcoma

Feb. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...